Browsing "Patents" by Title :
Showing results 441 to 460 of 525
| Pub Year | | Title | Author(s) |
| 2019 | | Pharmaceutical composition comprising extract of Cleyera japonica or fermented extract of Cleyera japonica for preventing or treating of respiratory diseases | 김미영, 정이숙 |
| - | | PHARMACEUTICAL COMPOSITION COMPRISING METHYLENE BLUE FOR TREATING OR PREVENTING SENSORINEURAL HEARING LOSS | 박상면, 박정섭 |
| 2016 | | Pharmaceutical composition comprising RIP3-MLKL pathway blocker for preventing or treating of skin cell necrosis disease | 구기방, 김유선 |
| - | | Pharmaceutical composition for antithrombotic comprising cilostazol and nitric oxide precursor | 홍지만 |
| 2017 | | Pharmaceutical composition for enhancing anticancer efficacy of 2-deoxyglucose comprising T-type calcium channel inhibitor | 윤준기, 이수진 |
| - | | PHARMACEUTICAL COMPOSITION FOR ENHANCING EFFECT OF ANTI-CANCER TREATING | 허훈 |
| - | | PHARMACEUTICAL COMPOSITION FOR ENHANCING EFFECT OF ANTI-CANCER TREATING | 허훈 |
| 2022 | | Pharmaceutical composition for preventing or treating angiogenesis relating ocular diseases comprising inhibitors of MCT expression or activity | 이기황 |
| - | | Pharmaceutical composition for preventing or treating Behcet's disease or rheumatoid arthritis comprising peptides or mixture thereof | 손성향 |
| - | | Pharmaceutical composition for preventing or treating bladder cancer comprising inducer or activator of BTG2 and screening method thereof | 임인경 |
| - | | Pharmaceutical composition for preventing or treating glaucoma comprising Vitis vinifera pip extract | 안재홍 |
| 2016 | | Pharmaceutical composition for preventing or treating hearing loss comprising carbenoxolon or its pharmaceutically acceptable salts as effective compound | 김연주, 정연훈 |
| 2017 | | Pharmaceutical composition for preventing or treating miRNA-34a related diseases comprising inducer or activator of TIS21 and screening method thereof | 유민숙, 임인경 |
| 2022 | | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NON-ALCOHOLIC FATTY LIVER DISEASE | 강엽, 정익락, 최성이 |
| - | | Pharmaceutical composition for preventing or treating SNCG overexpression disease comprising an AZ-628 as an active ingredient | 양시영 |
| - | | Pharmaceutical composition for preventing or treating SNCG overexpression disease comprising an PD-184352 as an active ingredient | 양시영 |
| - | | Pharmaceutical Composition for Preventing or Treating Synucleinopathy Comprising Expression or Activation Inhibitor of c-src | 박상면, 최유리 |
| - | | Pharmaceutical composition for the prevention or treatment of diseases associated with immune dysregulation comprising oxidized immunoglobulin | 남동호 |
| - | | Pharmaceutical composition for the prevention or treatment of diseases associated with immune dysregulation comprising oxidized immunoglobulin | 남동호 |
| 2017 | | Pharmaceutical composition for treating CNS injury-related diseases comprising CCL2 or CCL2 agonist | 권민정, 김병곤 |
